Inventor
GOEPFERT ULRICH
DE26 patents
⚠️ This page may combine multiple inventors who share the name “GOEPFERT ULRICH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
23 patentsUS10323089B2Jun 18, 2019
Anti-transferrin receptor antibodies with tailored affinity
HOFFMANN LA ROCHE25 citations94
US9290567B2Mar 22, 2016
Use of an anti-Tau pS422 antibody for the treatment of brain diseases
HOFFMANN LA ROCHE25 citations92
US11603411B2Mar 14, 2023
Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use
HOFFMANN LA ROCHE9 citations85
US11584793B2Feb 21, 2023
Anti-transferrin receptor antibodies with tailored affinity
HOFFMANN LA ROCHE8 citations85
US10941205B2Mar 9, 2021
Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use
HOFFMANN LA ROCHE10 citations85
US10822402B2Nov 3, 2020
Humanized anti-tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE4 citations83
US9862763B2Jan 9, 2018
Humanized anti-tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE4 citations83
US12252533B2Mar 18, 2025
Anti-transferrin receptor antibodies with tailored affinity
HOFFMANN LA ROCHE1 citations74
US11787868B2Oct 17, 2023
Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use
HOFFMANN LA ROCHE1 citations72
US10465000B2Nov 5, 2019
Humanized anti-Tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE2 citations72
US10251952B2Apr 9, 2019
Humanized anti-tau(pS422) antibody brain shuttles and use thereof
HOFFMANN LA ROCHE5 citations72
US9562091B2Feb 7, 2017
Humanized anti-Tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE4 citations72
US12358997B1Jul 15, 2025
Bispecific anti-human A-beta/anti-human transferrin receptor antibodies
HOFFMANN LA ROCHE0 citations62
US12297263B2May 13, 2025
Humanized anti-Tau(PS422) antibodies and methods of use
HOFFMANN LA ROCHE0 citations62
US12030952B2Jul 9, 2024
Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use
HOFFMANN LA ROCHE1 citations62
US11572404B2Feb 7, 2023
Humanized anti-Tau(pS422) antibodies and methods of use
HOFFMANN LA ROCHE0 citations62
US11332797B2May 17, 2022
Method for the selection of a long-term producing cell using histone acylation as markers
HOFFMANN LA ROCHE1 citations57
US12312606B2May 27, 2025
Nucleic acid constructs for VA RNA transcription
HOFFMANN LA ROCHE0 citations53
US12529050B2Jan 20, 2026
Multispecific antibody screening method using recombinase mediated cassette exchange
HOFFMANN LA ROCHE0 citations52
US9428766B2Aug 30, 2016
Protein expression from multiple nucleic acids
HOFFMANN LA ROCHE0 citations52
US7892790B2Feb 22, 2011
Protein expression in rodent cells
HOFFMANN LA ROCHE0 citations52
US10329595B2Jun 25, 2019
CMV promoter and method for production of polypeptides
HOFFMANN LA ROCHE0 citations44
US10151002B2Dec 11, 2018
Method for the selection of a long-term producing cell
HOFFMANN LA ROCHE1 citations39